Twist Bioscience Corporation
TWST
$55.95
-$0.26-0.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.77% | 18.59% | 20.32% | 22.72% | 25.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.77% | 18.59% | 20.32% | 22.72% | 25.30% |
| Cost of Revenue | 5.91% | 3.53% | 3.31% | 4.73% | 8.22% |
| Gross Profit | 31.32% | 37.30% | 43.24% | 49.12% | 52.80% |
| SG&A Expenses | 18.79% | 17.50% | 13.08% | 11.15% | 13.81% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.38% | 6.54% | 4.90% | 4.77% | 7.52% |
| Operating Income | 15.76% | 17.76% | 22.54% | 23.65% | 18.27% |
| Income Before Tax | 57.79% | 61.53% | 63.03% | 61.42% | 0.26% |
| Income Tax Expenses | 102.72% | 63.13% | 28.57% | -15.44% | -57.57% |
| Earnings from Continuing Operations | 57.48% | 61.19% | 62.79% | 61.33% | 0.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.48% | 61.19% | 62.79% | 61.33% | 0.52% |
| EBIT | 15.76% | 17.76% | 22.54% | 23.65% | 18.27% |
| EBITDA | 16.16% | 17.23% | 21.94% | 22.15% | 17.03% |
| EPS Basic | 59.40% | 62.54% | 63.81% | 62.11% | 2.75% |
| Normalized Basic EPS | 18.98% | 20.56% | 25.27% | 24.21% | 19.05% |
| EPS Diluted | 59.12% | 62.26% | 63.55% | 61.82% | 2.71% |
| Normalized Diluted EPS | 19.35% | 20.91% | 25.60% | 24.52% | 19.05% |
| Average Basic Shares Outstanding | 3.27% | 3.21% | 3.13% | 2.89% | 2.58% |
| Average Diluted Shares Outstanding | 3.76% | 3.71% | 3.63% | 3.39% | 2.58% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |